Abstract
Grapefruit juice and grapefruit product consumption have potential health benefits; however, their intake is also associated with interactions with certain drugs, including calcium channel blockers, immunosuppressants and antihistamines. The primary mechanism through which interactions are mediated is mechanism-based intestinal cytochrome P450 3A4 inhibition by furanocoumarins resulting in increased bioavailability of administered medications that are substrates. Grapefruit products have also been associated with interactions with P-glycoprotein (P-gp) and uptake transporters (e.g. organic anion-transporting polypeptides [OATPs]). Polyphenolic compounds such as flavonoids have been proposed as the causative agents of the P-gp and OATP interactions. The mechanisms and magnitudes of the interactions can be influenced by the concentrations of furanocoumarins and flavonoids in the grapefruit product, the volume of juice consumed, and the inherent variability of specific enzymes and transporter components in humans. It is therefore challenging to predict the extent of grapefruit product-drug interactions and to compare available in vitro and in vivo data. The clinical significance of such interactions also depends on the disposition and toxicity profile of the drug being administered. The aim of this review is to outline the mechanisms of grapefruit-drug interactions and present a comprehensive summary of those agents affected and whether they are likely to be of clinical relevance.
Similar content being viewed by others
References
Mertens-Talcott SU, Zadezensky I, De Castro WV, et al. Grapefruit-drug interactions: can interactions with drugs be avoided? J Clin Pharmacol 2006 Dec; 46(12): 1390–416
Gmitter Jr FG. Origin, evolution and breeding of the grapefruit. Plant Breed Rev 1995; 13: 345–63
Nicolosi E, Deng ZN, Gentile A, et al. Citrus phylogeny and genetic origin of important species as investigated by molecular markers. Theor Appl Genet 2000; 100(8): 1155–66
Moore GA. Oranges and lemons: clues to the taxonomy of Citrus from molecular markers. Trends Genet 2001 Sep; 17(9): 536–40
Bailey DG, Spence JD, Edgar B, et al. Ethanol enhances the hemodynamic effects of felodipine. Clin Invest Med 1989 Dec; 12(6): 357–62
Bailey DG, Dresser GK. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 2004; 4(5): 281–97
Neuvonen PJ, Backman JT, Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin Pharmacokinet 2008; 47(7): 463–74
Sica DA. Interaction of grapefruit juice and calcium channel blockers. Am J Hypertens 2006 Jul; 19(7): 768–73
Hukkinen SK, Varhe A, Olkkola KT, et al. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin Pharmacol Ther 1995 Aug; 58(2): 127–31
Kupferschmidt HH, Ha HR, Ziegler WH, et al. Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 1995 Jul; 58(1): 20–8
Ozdemir M, Aktan Y, Boydag BS, et al. Interaction between grapefruit juice and diazepam in humans. Eur J Drug Metab Pharmacokinet 1998 Jan-Mar; 23(1): 55–9
Benton RE, Honig PK, Zamani K, et al. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin Pharmacol Ther 1996 Apr; 59(4): 383–8
Clifford CP, Adams DA, Murray S, et al. The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice. Eur J Clin Pharmacol 1997; 52(4): 311–5
Honig PK, Wortham DC, Lazarev A, et al. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 1996 Apr; 36(4): 345–51
Rau SE, Bend JR, Arnold MO, et al. Grapefruit juiceterfenadine single-dose interaction: magnitude, mechanism, and relevance. Clin Pharmacol Ther 1997 Apr; 61(4): 401–9
Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995 May; 57(5): 485–91
Hollander AA, van Rooij J, Lentjes GW, et al. The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin Pharmacol Ther 1995 Mar; 57(3): 318–24
Min DI, Ku YM, Perry PJ, et al. Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. Transplantation 1996 Jul 15; 62(1): 123–5
Yee GC, Stanley DL, Pessa LJ, et al. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995 Apr 15; 345(8955): 955–6
Goosen TC, Cillie D, Bailey DG, et al. Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans. Clin Pharmacol Ther 2004 Dec; 76(6): 607–17
He K, Iyer KR, Hayes RN, et al. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol 1998 Apr; 11(4): 252–9
Edwards DJ, Bellevue 3rd FH, Woster PM. Identification of 60,70-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos 1996 Dec; 24(12): 1287–90
Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, et al. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 1997 Nov;25(11): 1228–33
Fukuda K, Ohta T, Oshima Y, et al. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics 1997 Oct; 7(5): 391–6
Guo LQ, Fukuda K, Ohta T, et al. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos 2000 Jul; 28(7): 766–71
Lilja JJ, Kivisto KT, Backman JT, et al. Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life. Eur J Clin Pharmacol 2000 Aug; 56(5): 411–5
Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clin Pharmacol Ther 1999 Aug; 66(2): 118–27
Nieminen TH, Hagelberg NM, Saari TI, et al. Grapefruit juice enhances the exposure to oral oxycodone. Basic Clin Pharmacol Toxicol 2010 Oct; 107(4): 782–8
Bailey DG, Spence JD, Munoz C, et al. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991 Feb 2; 337(8736): 268–9
Lundahl J, Regardh CG, Edgar B, et al. Effects of grapefruit juice ingestion — pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol 1997; 52(2): 139–45
Lown KS, Bailey DG, Fontana RJ, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997 May 15; 99(10): 2545–53
Lundahl J, Regardh CG, Edgar B, et al. Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 1995; 49(1–2): 61–7
Lin JH, Lu AY. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annu Rev Pharmacol Toxicol 2001; 41: 535–67
Paine MF, Khalighi M, Fisher JM, et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 1997 Dec; 283(3): 1552–62
Bailey DG, Arnold JM, Munoz C, et al. Grapefruit juice-felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther 1993 Jun; 53(6): 637–42
Bailey DG, Arnold JM, Strong HA, et al. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther 1993 Dec; 54(6): 589–94
Bailey DG, Dresser GK, Kreeft JH, et al. Grapefruitfelodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther 2000 Nov; 68(5): 468–77
Paine MF, Criss AB, Watkins PB. Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties. Drug Metab Dispos 2004 Oct; 32(10): 1146–53
Paine MF, Criss AB, Watkins PB. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition. J Pharmacol Exp Ther 2005 Mar; 312(3): 1151–60
Paine MF, Widmer WW, Hart HL, et al. A furanocoumarinfree grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. Am J Clin Nutr 2006 May; 83(5): 1097–105
Girennavar B, Jayaprakasha GK, Patil BS. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins. J Food Sci 2007 Oct; 72(8): C417–21
Tassaneeyakul W, Guo LQ, Fukuda K, et al. Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch Biochem Biophys 2000 Jun 15; 378(2): 356–63
Fuhr U, Klittich K, Staib AH. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 1993 Apr; 35(4): 431–6
Lin HL, Kent UM, Hollenberg PF. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5. J Pharmacol Exp Ther 2005 Apr; 313(1): 154–64
Baumgart A, Schmidt M, Schmitz HJ, et al. Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes. Biochem Pharmacol 2005 Feb 15; 69(4): 657–67
Tassaneeyakul W, Vannaprasaht S, Yamazoe Y. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. Br J Clin Pharmacol 2000 Feb; 49(2): 139–44
Uno T, Yasui-Furukori N, Takahata T, et al. Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes. J Clin Pharmacol 2005 Jun; 45(6): 690–4
Lane HY, Jann MW, Chang YC, et al. Repeated ingestion of grapefruit juice does not alter clozapine’s steady-state plasma levels, effectiveness, and tolerability. J Clin Psychiatry 2001 Oct; 62(10): 812–7
Fuhr U, Maier A, Keller A, et al. Lacking effect of grapefruit juice on theophylline pharmacokinetics. Int J Clin Pharmacol Ther 1995 Jun; 33(6): 311–4
Oesterheld J, Kallepalli BR. Grapefruit juice and clomipramine: shifting metabolitic ratios. J Clin Psychopharmacol 1997 Feb; 17(1): 62–3
Sullivan DM, Ford MA, Boyden TW. Grapefruit juice and the response to warfarin. Am J Health Syst Pharm 1998 Aug 1; 55(15): 1581–3
Takanaga H, Ohnishi A, Matsuo H, et al. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. Biol Pharm Bull 1998 Oct; 21(10): 1062–6
Ikegawa T, Ushigome F, Koyabu N, et al. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett 2000 Nov 10; 160(1): 21–8
Edwards DJ, Bernier SM. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. Life Sci 1996; 59(13): 1025–30
Takanaga H, Ohnishi A, Yamada S, et al. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. J Pharmacol Exp Ther 2000 Apr; 293(1): 230–6
Honda Y, Ushigome F, Koyabu N, et al. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br J Pharmacol 2004 Dec; 143(7): 856–64
de Castro WV, Mertens-Talcott S, Derendorf H, et al. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. J Pharm Sci 2007 Oct; 96(10): 2808–17
Dahan A, Amidon GL. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein. Pharm Res 2009 Apr; 26(4): 883–92
Becquemont L, Verstuyft C, Kerb R, et al. Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin Pharmacol Ther 2001 Oct; 70(4): 311–6
Dresser GK, Bailey DG, Leake BF, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002 Jan; 71(1): 11–20
Glaeser H, Bailey DG, Dresser GK, et al. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther 2007 Mar; 81(3): 362–70
Satoh H, Yamashita F, Tsujimoto M, et al. Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 2005 Apr; 33(4): 518–23
Lilja JJ, Niemi M, Fredrikson H, et al. Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide. Br J Clin Pharmacol 2007 Jun; 63(6): 732–40
Lilja JJ, Backman JT, Laitila J, et al. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol. Clin Pharmacol Ther 2003 Mar; 73(3): 192–8
Schwarz UI, Seemann D, Oertel R, et al. Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin Pharmacol Ther 2005 Apr; 77(4): 291–301
Kato Y, Miyazaki T, Kano T, et al. Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol. J Pharm Sci 2009 Jul; 98(7): 2529–39
Shirasaka Y, Kuraoka E, Spahn-Langguth H, et al. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. J Pharmacol Exp Ther 2010 Jan; 332(1): 181–9
Tapaninen T, Neuvonen PJ, Niemi M. Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren. Clin Pharmacol Ther 2010 Sep; 88(3): 339–42
Bailey DG, Dresser GK, Leake BF, et al. Naringin is a major and selective clinical inhibitor of organic aniontransporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther 2007 Apr; 81(4): 495–502
Nishimuta H, Ohtani H, Tsujimoto M, et al. Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. Biopharm Drug Dispos 2007 Dec; 28(9): 491–500
Li P, Callery PS, Gan LS, et al. Esterase inhibition attribute of grapefruit juice leading to a new drug interaction. Drug Metab Dispos 2007 Jul; 35(7): 1023–31
Dresser GK, Kim RB, Bailey DG. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Clin Pharmacol Ther 2005 Mar; 77(3): 170–7
De Castro WV, Mertens-Talcott S, Rubner A, et al. Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juicedrug interaction studies. J Agric Food Chem 2006 Jan 11; 54(1): 249–55
Garg SK, Kumar N, Bhargava VK, et al. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 1998 Sep; 64(3): 286–8
Tegretol Retard (carbamazepine 200mg, 400mg tablets): summary of product characterisitics. Novartis Pharmaceuticals UK Ltd. Updated 09/12/2009 [online]. Available from URL: http://www.medicines.org.uk 1330 [Accessed 2010 Feb 1]
Tegretol® (carbamazepine) tablets, suspension: US prescribing information. Novartis Pharmaceutical corp. Revised February 2009 [online]. Available from URL: http://www.pharma.us.novartis.com/product/pi/pdf/tegretol.pdf [Accessed 2010 Jul 17]
Banfield C, Gupta S, Marino M, et al. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine. Clin Pharmacokinet 2002; 41(4): 311–8
Telfast (fexofenadine) tablets: summary of product characteristics, sanofi-aventis. Updated 06/01/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jan 3]
Allegra (fexofenadine) tablets: US prescribing information. sanofi-aventis US. Updated 07/2007 [online]. Available from URL: http://products.sanofi-aventis.us/allegra/allegra_ODT.pdf [Accessed 2010 Jul 15]
van Agtmael MA, Gupta V, van der Graaf CA, et al. The effect of grapefruit juice on the time-dependent decline of artemether plasma levels in healthy subjects. Clin Pharmacol Ther 1999 Oct; 66(4): 408–14
van Agtmael MA, Gupta V, van der Wosten TH, et al. Grapefruit juice increases the bioavailability of artemether. Eur J Clin Pharmacol 1999 Jul; 55(5): 405–10
Riamet (artemether/lumefantrine 20/120mg tablets): summary of product characteristics. Novartis Pharmaceuticals UK Ltd. Updated 21/09/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Coartem (artemether/lumefantrine) tablets: US prescribing information. Novartis Pharmaceuticals Corp. Updated February 2010 [online]. Available from URL: http://www.pharma.us.novartis.com/product/pi/pdf/coartem.pdf [Accessed 2010 Jul 16]
Cuong BT, Binh VQ, Dai B, et al. Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects? Br J Clin Pharmacol 2006 Jun; 61(6): 682–9
Primaquine phosphate tablets, USP: US prescribing information. Sanofi-Synthelabo Inc. Revised April 2003 [online]. Available from URL: http://products.sanofiaventis.us/primaquine/primaquine.html [Accessed 2010 Jul 17]
Orap (pimozide) 4mg tablets: summary of product characteristics. Janssen-Cilag Ltd. Updated 15/02/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Sep 28]
Andersen V, Pedersen N, Larsen NE, et al. Intestinal first pass metabolism of midazolam in liver cirrhosis: effect of grapefruit juice. Br J Clin Pharmacol 2002 Aug; 54(2): 120–4
Vanakoski J, Mattila MJ, Seppala T. Grapefruit juice does not enhance the effects of midazolam and triazolam in man. Eur J Clin Pharmacol 1996; 50(6): 501–8
Sugimoto K, Araki N, Ohmori M, et al. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam. Eur J Clin Pharmacol 2006 Mar; 62(3): 209–15
Halcion® (triazolam) tablets: US prescribing information. Pfizer Inc. Updated 12/2008 [online]. Available from URL: http://media.pfizer.com/files/products/uspi_halcion.pdf [Accessed 2010 Jul 26]
Gammans RE, Mayol RF, Mackenthun AV, et al. The relationship between buspirone bioavailability and dose in healthy subjects. Biopharm Drug Dispos 1985 Apr–Jun; 6(2): 139–45
Lilja JJ, Kivisto KT, Backman JT, et al. Grapefruit juice substantially increases plasma concentrations of buspirone. Clin Pharmacol Ther 1998 Dec; 64(6): 655–60
Buspar (buspirone 5mg and 10mg tablets): patient information leaflet. E. R. Squibb & Sons Limited. Updated 10/03/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
BuSpar® (buspirone hydrochloride tablets USP) tablets: US prescribing information. Bristol-Myers Squibb Company. Revised March 2007 [online]. Available from URL: http://packageinserts.bms.com/pi/pi_buspar.pdf [Accessed 2010 Jul 15]
Libersa CC, Brique SA, Motte KB, et al. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice. Br J Clin Pharmacol 2000 Apr; 49(4): 373–8
Codarone (amiodarone) tablets: summary of product characteristics. sanofi-aventis. Updated 15/07/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 26]
Cordarone® (amiodarone HCl) tablets: US prescribing information. Wyeth Pharmaceuticals Inc. Updated 08/2009 [online]. Available from URL: http://www.wyeth.com/content/showlabeling.asp?id=93 [Accessed 2010 Jul 26]
Arythmol (propafenone 150mg and 300mg tablets): summary of product characteristics. Abbott Laboratories Ltd. Updated 08/01/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Rhythmol® (propafenone hydrochloride) tablets: US prescribing information. GlaxoSmithKline. October 2009 [online]. Available from URL: http://us.gsk.com/products/assets/us_rythmol.pdf [Accessed 2010 Jul 17]
Multaq (dronedarone) 400mg tablets: summary of product characteristics. Sanofi-Aventis. Updated 31/03/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Sep 28]
Multaq (dronedarone) 400mg tablets: US prescribing information, sanofi-aventis. Issued July 2009 [online]. Available from URL: http://products.sanofi-aventis.us/Multaq/Multaq.pdf [Accessed 2010 Sep 28]
Fuhr U, Muller-Peltzer H, Kern R, et al. Effects of grapefruit juice and smoking on verapamil concentrations in steady state. Eur J Clin Pharmacol 2002 Apr; 58(1): 45–53
Ho PC, Ghose K, Saville D, et al. Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers. Eur J Clin Pharmacol 2000 Dec; 56(9–10): 693–8
Zaidenstein R, Dishi V, Gips M, et al. The effect of grapefruit juice on the pharmacokinetics of orally administered verapamil. Eur J Clin Pharmacol 1998 Jun; 54(4): 337–40
Covera-HS (verapamil hydrochloride) controlled release tablets: US prescribing information. Pfizer Inc. Revised February 2010 [online]. Available from URL: http://www.pfizer.com/files/products/uspi_covera.pdf [Accessed 2010 Jul 15]
Nakagawa K, Goto T. Effects of ingestion of grapefruit juice or grapefruit on the hypotensive effect and plasma concentrations of dihydropyridine calcium antagonists (amlodipine and nifedipine): a case study. Clin Exp Hypertens 2010 Jan; 32(2): 71–5
Josefsson M, Zackrisson AL, Ahlner J. Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers. Eur J Clin Pharmacol 1996; 51(2): 189–93
Vincent J, Harris SI, Foulds G, et al. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine. Br J Clin Pharmacol 2000 Nov; 50(5): 455–63
Amlostin (amlodipine maleate) tablets: summary of product characteristics. Discovery Pharmaceuticals Ltd. Updated 19/02/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 22]
Norvasc (amlodipine besylate) tablets: US prescribing information. Pfizer Inc. Revised March 2010 [online]. Available from URL: http://www.pfizer.com/files/products/uspi_norvasc.pdf [Accessed 2010 Jul 22]
Istin (amlodipine besilate) tablets: summary of product characteristics. Pfizer Ltd. Updated 01/04/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 22]
Bailey DG, Arnold JM, Bend JR, et al. Grapefruit juicefelodipine interaction: reproducibility and characterization with the extended release drug formulation. Br J Clin Pharmacol 1995 Aug; 40(2): 135–40
Bailey DG, Kreeft JH, Munoz C, et al. Grapefruit juicefelodipine interaction: effect of naringin and 6′,7′-dihydroxybergamottin in humans. Clin Pharmacol Ther 1998 Sep; 64(3): 248–56
Malhotra S, Bailey DG, Paine MF, et al. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther 2001 Jan; 69(1): 14–23
Dresser GK, Bailey DG, Carruthers SG. Grapefruit juice: felodipine interaction in the elderly. Clin Pharmacol Ther 2000 Jul; 68(1): 28–34
Edgar B, Bailey D, Bergstrand R, et al. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine: and its potential clinical relevance. Eur J Clin Pharmacol 1992; 42(3): 313–7
Uno T, Ohkubo T, Sugawara K, et al. Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site. Eur J Clin Pharmacol 2000 Dec; 56(9–10): 643–9
Cardene SR (nicardipine hydrochloride) sustained release capsules: summary of product characteristics. Astellas Pharma Ltd. Updated 19/04/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 22]
Fuhr U, Maier-Bruggemann A, Blume H, et al. Grapefruit juice increases oral nimodipine bioavailability. Int J Clin Pharmacol Ther 1998 Mar; 36(3): 126–32
Nimotop (nimodipine) tablets: summary of product characteristics. Bayer Plc. Updated 17/06/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 22]
Odou P, Ferrari N, Barthelemy C, et al. Grapefruit juicenifedipine interaction: possible involvement of several mechanisms. J Clin Pharm Ther 2005 Apr; 30(2): 153–8
Rashid J, McKinstry C, Renwick AG, et al. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br J Clin Pharmacol 1993 Nov; 36(5): 460–3
Adigun AQ, Mudasiru Z. Clinical effects of grapefruit juice-nifedipine interaction in a 54-year-old Nigerian: a case report. J Natl Med Assoc 2002 Apr; 94(4): 276–8
Adalat (nifedipine) capsules: summary of product characteristics. Bayer Plc. Updated 01/07/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 22]
Procardia® (nifedipine) capsules: US prescribing information. Pfizer Inc. Revised March 2006 [online]. Available from URL: http://www.pfizer.com/files/products/uspi_procardia.pdf [Accessed 2010 Jul 22]
Prescal (isradipine) tablets: summary of product characteristics. Novartis Pharmaceuticals UK Ltd. Updated 12/12/2007 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 26]
Motens (lacidipine) tablets: summary of product characteristics. Boehringer Ingelheim Ltd. Updated 24/05/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 26]
Lercanidipine tablets: summary of product characteristics. Winthrop Pharmaceuticals UK Ltd. Updated 03/02/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 26]
DYNACIRC CR (isradipine) controlled release tablets: US prescribing information. GlaxoSmithKline. February 2009 [online]. Available from URL: http://us.gsk.com/products/assets/us_dynacirc_cr.pdf [Accessed 2010 Jul 15]
Takanaga H, Ohnishi A, Murakami H, et al. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clin Pharmacol Ther 2000 Mar; 67(3): 201–14
Sular (nisoldipine) extended release tablet: US prescribing information. Shionogi Pharma, Inc. Revised 02/2010 [online]. Available from URL: http://www.sular.com/pdf/Sular_PI.pdf [Accessed 2010 Jul 17]
Fukazawa I, Uchida N, Uchida E, et al. Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese. Br J Clin Pharmacol 2004 Apr; 57(4): 448–55
Ando H, Tsuruoka S, Yanagihara H, et al. Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin. Br J Clin Pharmacol 2005 Nov; 60(5): 494–7
Lipitor (atorvastatin calcium) tablets: US prescribing information. Pfizer Inc. Updated 06/2009 [online]. Available from URL: http://www.pfizer.com/files/products/uspi_lipitor.pdf [Accessed 2010 Jul 13]
Kantola T, Kivisto KT, Neuvonen PJ. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1998 Apr; 63(4): 397–402
Mevacor (lovastatin) tablets: US prescribing information. Merck & Co Inc. Issued May 2010 [online]. Available from URL: http://www.merck.com/product/usa/pi_circulars/m/mevacor/mevacor_pi.pdf [Accessed 2010 Jul 15]
Lilja JJ, Neuvonen M, Neuvonen PJ. Effects of regular iconsumption of grapefruit juice on the pharmacokinetics of simvastatin. Br J Clin Pharmacol 2004 Jul; 58(1): 56–60
Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juicesimvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 1998 Nov; 64(5): 477–83
Lilja JJ, Kivisto KT, Neuvonen PJ. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Clin Pharmacol Ther 2000 Oct; 68(4): 384–90
Dreier JP, Endres M. Statin-associated rhabdomyolysis triggered by grapefruit consumption. Neurology 2004 Feb 24; 62(4): 670
Zocor Heart-Pro (simvastatin 10mg film coated tablets). McNeil Ltd. Updated 06/11/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Zocor (simvastatin) tablets: US prescribing information. Merck & Co Inc. Issued May 2010 [online]. Available from URL: http://www.merck.com/product/usa/pi_circulars/z/zocor/zocor_pi.pdf [Accessed 2010 Jul 13]
Procoralan (ivabradine 5mg and 7.5mg film coated tablets): summary of product characteristics. Servier Laboratories Limited. Updated 13/11/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Ranexa (ranolazine 375mg, 500mg and 750mg prolongedrelease tablets): summary of product characteristics. A.Menarini Pharma U.K. S.R.L. Updated 10/08/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Ranexa (ranolazine) extended release tablets: US prescribing information. Gilead Sciences Inc. Revised 09/2009 [online]. Available from URL: http://www.ranexa.com/download/RanexaPI.PDF [Accessed 2010 Jul 22]
EntocortCR (budesonide) 3mg capsules: summary of product characteristics. AstraZeneca UK Limited. Updated 26/11/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 28/09/2010]
EntocortEC (budesonide) 3mg capsules. AstraZeneca. Revised 06/2009 [online]. Available from URL: http://www1.astrazeneca-us.com/pi/entocortec.pdf [Accessed 2010 Sep 28]
Yin OQ, Gallagher N, Li A, et al. Effect of grapefruit juice on the pharmacokinetics of nilotinib in healthy participants. J Clin Pharmacol 2010 Feb; 50(2): 188–94
Tasigna (nilotinib) capsules: summary of product characteristics. Novartis Pharmaceuticals UK Ltd. Updated 03/03/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 22]
Tasigna (nilotinib) capsules: US prescribing information. Novartis Inc. Updated 06/2010 [online]. Available from URL: http://www.pharma.us.novartis.com/product/pi/pdf/tasigna.pdf [Accessed 2010 Jul 22]
Tyverb (lapatinib) tablets: summary of product characteristics. GlaxoSmithKline UK. Updated 24/06/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 22]
Tykerb (lapatinib) tablets: summary of product characteristics. GlaxoSmithKline. Revised April 2010 [online]. Available from URL: http://us.gsk.com/products/assets/us_tykerb.pdf [Accessed 2010 Jul 22]
Sutent (sunitinib) capsules: summary of product characteristics. Pfizer Ltd. Updated 09/07/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 22]
Sutent (sunitinib maleate) capsules: US prescribing information. Pfizer Inc. Issued July 2010 [online]. Available from URL: http://www.pfizer.com/files/products/uspi_sutent.pdf [Accessed 2010 Jul 22]
Sprycel (dasatinib) tablets: US prescribing information. Bristol-Myers Squibb Company. Updated 06/2009 [online]. Available from URL: http://packageinserts.bms.com/pi/pi_sprycel.pdf [Accessed 2010 Jul 22]
Tarceva (erlotinib) tablets: US prescribing information. OSI Pharmaceuticals Inc. Revised 04/2010 [online]. Available from URL: http://www.osip.com/pdf/Tarceva_PI_042010.pdf [Accessed 2010 Jul 22]
Gleevec (imatinib mesylate) tablets: US prescribing information. Novartis Inc. Updated 02/2010 [online]. Available from URL: http://www.pharma.us.novartis.com/product/pi/pdf/gleevec_tabs.pdf [Accessed 2010 Jul 22]
Torisel (temsirolimus) IV injection: US prescribing information. Wyeth Pharmaceuticals Inc. Revised 07/2010 [online]. Available from URL: http://www.wyeth.com/content/showlabeling.asp?id=490 [Accessed 2010 Jul 22]
Kivisto KT, Lilja JJ, Backman JT, et al. Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride. Clin Pharmacol Ther 1999 Nov; 66(5): 448–53
Propulsid (cisapride) official FDA information. FDA Professional Drug information. Updated 10/2009 [online]. Available from URL: http://www.drugs.com/pro/propulsid.html [Accessed 2010 Jul 13]
Bistrup C, Nielsen FT, Jeppesen UE, et al. Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients. Nephrol Dial Transplant 2001 Feb; 16(2): 373–7
Brunner LJ, Pai KS, Munar MY, et al. Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients. Pediatr Transplant 2000 Nov; 4(4): 313–21
Ducharme MP, Provenzano R, Dehoorne-Smith M, et al. Trough concentrations of cyclosporine in blood following administration with grapefruit juice. Br J Clin Pharmacol 1993 Nov; 36(5): 457–9
Edwards DJ, Fitzsimmons ME, Schuetz EG, et al. 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 1999 Mar; 65(3): 237–44
Ku YM, Min DI, Flanigan M. Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does the formulation difference matter? J Clin Pharmacol 1998 Oct; 38(10): 959–65
Lee M, Min DI, Ku YM, et al. Effect of grapefruit juice on pharmacokinetics of microemulsion cyclosporine in African American subjects compared with Caucasian subjects: does ethnic difference matter? J Clin Pharmacol 2001 Mar; 41(3): 317–23
Mehrsai AR, Pourmand G, Mansour D, et al. Effect of grapefruit juice on serum concentration of cyclosporine in Iranian renal transplant patients. Transplant Proc 2003 Nov; 35(7): 2739–41
Proppe DG, Hoch OD, McLean AJ, et al. Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function. Br J Clin Pharmacol 1995 Mar; 39(3): 337–8
Paine MF, Widmer WW, Pusek SN, et al. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. Am J Clin Nutr 2008 Apr 1; 87(4): 863–71
Schwarz UI, Johnston PE, Bailey DG, et al. Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition. Br J Clin Pharmacol 2006 Oct; 62(4): 485–91
Neoral (ciclosporin) capsules/oral solution: US prescribing information. Novartis Pharmaceuticals Corp. Revised October 2009 [online]. Available from URL: http://www.pharma.us.novartis.com/product/pi/pdf/neoral.pdf [Accessed 2010 Jul 17]
Liu C, Shang YF, Zhang XF, et al. Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study. Eur J Clin Pharmacol 2009 Sep; 65(9): 881–5
Fukatsu S, Fukudo M, Masuda S, et al. Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient. Drug Metab Pharmacokinet 2006 Apr; 21(2): 122–5
Peynaud D, Charpiat B, Vial T, et al. Tacrolimus severe overdosage after intake of masked grapefruit in orange marmalade. Eur J Clin Pharmacol 2007 Jul; 63(7): 721–2
Prograf (tacrolimus) capsules: summary of product characteristics. Astellas Pharma Ltd. Updated 25/05/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 2]
Prograf® (tacrolimus) capsules: US prescribing information. Astellas Pharma US Inc. Revised August 2009 [online]. Available from URL: http://www.astellas.us/docs/prograf.pdf [Accessed 2010 Jul 17]
Rapamune (sirolimus) tablets: summary of product characteristics. Wyeth Pharmaceuticals. Updated 27/07/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 27]
Rapamune (sirolimus) tablets: US prescribing information. Wyeth Pharmaceuticals Inc. Updated 07/2010 [online]. Available from URL: http://www.wyeth.com/content/showlabeling.asp?id=139 [Accessed 2010 Jul 27]
Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, et al. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther 2002 Jan; 71(1): 21–9
Lee M, Min DI. Determination of sildenafil citrate in plasma by high-performance liquid chromatography and a case for the potential interaction of grapefruit juice with sildenafil citrate. Ther Drug Monit 2001 Feb; 23(1): 21–6
Viagra (sildenafil citrate) tablets: summary of product characteristics. Pfizer Ltd. Updated 19/07/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 27]
Viagra® (sildenafil citrate) tablets: US prescribing information. Pfizer Inc. January 2010 [online]. Available from URL: http://www.pfizer.com/files/products/uspi_viagra.pdf [Accessed 2010 Jul 16]
Cialis (tadalafil) tablets: summary of product characteristics. Eli Lilly and Company Limited. Updated 23/04/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 27]
Cialis (tadalafil) tablet: US prescribing information. Eli Lilly &Co. Revised February 1, 2010 [online]. Available from URL: http://pi.lilly.com/us/cialis-pi.pdf [Accessed 2010 Jul 13]
Levitra (vardenafil) tablets: summary of product characteristics. Bayer Plc. Updated 16/07/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jan 13]
Levitra (vardenafil) tablets: US prescribing information. Bayer Healthcare Pharmaceuticals Inc. Updated 05/2010 [online]. Available from URL: http://www.univgraph.com/bayer/inserts/levitra.pdf [Accessed 2010 Jul 17]
Emselex (darifenacin) prolonged release tablets: summary of product characteristics. Novartis Pharmaceuticals UK Ltd. Updated 25/03/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Sep 28]
Castro N, Jung H, Medina R, et al. Interaction between grapefruit juice and praziquantel in humans. Antimicrob Agents Chemother 2002 May; 46(5): 1614–6
Nagy J, Schipper HG, Koopmans RP, et al. Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. Am J Trop Med Hyg 2002 Mar; 66(3): 260–3
Awadzi K, Hero M, Opoku NO, et al. The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. Trop Med Parasitol 1994 Sep; 45(3): 203–8
Cheng KL, Nafziger AN, Peloquin CA, et al. Effect of grapefruit juice on clarithromycin pharmacokinetics. Antimicrob Agents Chemother 1998 Apr; 42(4): 927–9
Kanazawa S, Ohkubo T, Sugawara K. The effects of grapefruit juice on the pharmacokinetics of erythromycin. Eur J Clin Pharmacol 2001 Jan–Feb; 56(11): 799–803
Abbas R, Chow CP, Browder NJ, et al. In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms. Hum Exp Toxicol 2000 Mar; 19(3): 178–84
Taniguchi K, Ohtani H, Ikemoto T, et al. Possible case of potentiation of the antiplatelet effect of cilostazol by grapefruit juice. J Clin Pharm Ther 2007 Oct; 32(5): 457–9
Pletal (cilostazol) 50mg tablets: summary of product characteristics. Otsuka Pharmaceuticals (UK) Ltd. Updated 03/09/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Pletal (cilostazol) tablets: US prescribing information. Otsuka Pharmaceuticals, Inc. Updated 05/2007 [online]. Available from URL: http://www.otsuka-us.com/documents/Pletal_PI.pdf [Accessed 2010 Jul 19]
van Rooij J, van der Meer F, Schoemaker HC, et al. Comparison of the effect of grapefruit juice and cimetidine on pharmacokinetics and anticoagulant effect of a single dose of acenocoumarol [abstract]. Br J Clin Pharmacol 1993; 35: 548P
Brandin H, Myrberg O, Rundlof T, et al. Adverse effects by artificial grapefruit seed extract products in patients on warfarin therapy. Eur J Clin Pharmacol 2007 Jun; 63(6): 565–70
Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996 Mar; 153(3): 311–20
Stockley’s drug interactions. 9th ed. London: Pharmaceutical Press, 2010 [online]. Available from URL: http://www.medicinescomplete.com [Accessed 2010 Nov 15]
Preskorn SH. Clinically relevant pharmacology of selective serotonin reuptake inhibitors: an overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet 1997; 32 Suppl. 1: 1–21
Obach RS, Cox LM, Tremaine LM. Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab Dispos 2005 Feb; 33(2): 262–70
Ueda N, Yoshimura R, Umene-Nakano W, et al. Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers. World J Biol Psychiatry 2009; 10 (4 Pt 3): 832–5
Lee AJ, Chan WK, Harralson AF, et al. The effects of grapefruit juice on sertraline metabolism: an in vitro and in vivo study. Clin Ther 1999 Nov; 21(11): 1890–9
Fabre LF, Abuzzahab FS, Amin M, et al. Sertraline safety and efficacy in major depression: a double-blind fixeddose comparison with placebo. Biol Psychiatry 1995 Nov 1; 38(9): 592–602
Sertraline (setraline 50mg and 100mg film coated tablets): summary of product characteristics. Wockhardt UK Ltd. Updated 11/06/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Zoloft (sertraline) tablets/oral solution: US prescribing information. Updated 10/2008 [online]. Available from URL: http://media.pfizer.com/files/products/uspi_zoloft.pdf [Accessed 2010 Jul 16]
DeSilva KE, Le Flore DB, Marston BJ, et al. Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine. AIDS 2001 Jul 6; 15(10): 1281–5
Fluoxetine (fluoxetine 20mg capsules): summary of product characteristics. Sandoz Ltd. Updated 23/12/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Prozac (fluoxetine hydrochloride): US prescribing information. Eli Lilly and Company. Revised October 29, 2009 [online]. Available from URL: http://pi.lilly.com/us/prozac.pdf [Accessed 2010 Jan 18]
Hori H, Yoshimura R, Ueda N, et al. Grapefruit juicefluvoxamine interaction: is it risky or not? J Clin Psychopharmacol 2003 Aug; 23(4): 422–4
Fluvoxamine (fluvoxamine 50mg & 100mg film coated tablets): summary of product characteristics. Wockhardt UK Ltd. Updated 02/09/2008 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Luvox® CR (fluvoxamine maleate) extended release capsules: US prescribing information. Solvay Pharmaceuticals Inc. Revised 02/2009 [online]. Available from URL: http://www.luvoxcr.com/LUVOX-CR-PI.pdf [Accessed 2010 Jul 15]
Bidstrup TB, Damkier P, Olsen AK, et al. The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide. Br J Clin Pharmacol 2006 Jan; 61(1): 49–57
Heykants J, Van Peer A, Van de Velde V, et al. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 1989; 32 Suppl. 1: 67–87
Kawakami M, Suzuki K, Ishizuka T, et al. Effect of grapefruit juice on pharmacokinetics of itraconazole in healthy subjects. Int J Clin Pharmacol Ther 1998 Jun; 36(6): 306–8
Penzak SR, Gubbins PO, Gurley BJ, et al. Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers. Ther Drug Monit 1999 Jun; 21(3): 304–9
Gubbins PO, Gurley BJ, Williams DK, et al. Examining sex-related differences in enteric itraconazole metabolism in healthy adults using grapefruit juice. Eur J Clin Pharmacol 2008 Mar; 64(3): 293–301
Cvetkovic M, Leake B, Fromm MF, et al. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 1999 Aug; 27(8): 866–71
Wanwimolruk S, Chalcroft S, Coville PF, et al. Pharmacokinetics of quinine in young and elderly subjects. Trans R Soc Trop Med Hyg 1991 Nov–Dec; 85(6): 714–7
Ho PC, Chalcroft SC, Coville PF, et al. Grapefruit juice has no effect on quinine pharmacokinetics. Eur J Clin Pharmacol 1999 Jul; 55(5): 393–8
Eiermann B, Engel G, Johansson I, et al. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. Br J Clin Pharmacol 1997; 44(5): 439–46
Raaska K, Neuvonen PJ. Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole. Eur J Clin Pharmacol 1998 Apr; 54(2): 167–70
Vandel S, Netillard C, Perault MC, et al. Plasma levels of clozapine and desmethylclozapine are unaffected by concomitant ingestion of grapefruit juice. Eur J Clin Pharmacol 2000 Jul; 56(4): 347–8
Ozdemir V, Kalow W, Okey AB, et al. Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C→A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine. J Clin Psychopharmacol 2001 Dec; 21(6): 603–7
Yasui N, Kondo T, Suzuki A, et al. Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice. Int Clin Psychopharmacol 1999 Mar; 14(2): 113–8
Demarles D, Gillotin C, Bonaventure-Paci S, et al. Singledose pharmacokinetics of amprenavir coadministered with grapefruit juice. Antimicrob Agents Chemother 2002 May; 46(5): 1589–90
Telzir (fosamprenavir) tablets: summary of product characteristics. ViiV Healthcare UK Ltd. Updated 19/5/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 12]
Chiba M, Hensleigh M, Lin JH. Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes: major role of CYP3A. Biochem Pharmacol 1997 Apr 25; 53(8): 1187–95
Penzak SR, Acosta EP, Turner M, et al. Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics. J Clin Pharmacol 2002 Oct; 42(10): 1165–70
Shelton MJ, Wynn HE, Hewitt RG, et al. Effects of grapefruit juice on pharmacokinetic exposure to indinavir in HIV-positive subjects. J Clin Pharmacol 2001 Apr; 41(4): 435–42
Kupferschmidt HH, Fattinger KE, Ha HR, et al. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol 1998 Apr; 45(4): 355–9
Invirase (saquinavir 500mg film-coated tablets): summary of product characteristics. Roche Products Limited. Updated 05/08/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Sustiva (efavirenz 600mg film coated tablets): summary of product characteristics. Bristol-Myers Squibb Pharmaceuticals Ltd. Updated 07/09/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 2005 Oct; 27(5): 655–65
Ebert U, Oertel R, Kirch W. Influence of grapefruit juice on scopolamine pharmacokinetics and pharmacodynamics in healthy male and female subjects. Int J Clin Pharmacol Ther 2000 Nov; 38(11): 523–31
Yasui N, Kondo T, Furukori H, et al. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam. Psychopharmacology (Berl) 2000 Jun; 150(2): 185–90
Lanoxin (digoxin 0.25mg tablets): summary of product characteristics. GlaxoSmithKline UK. Updated 08/03/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 1]
Parker RB, Yates CR, Soberman JE, et al. Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans. Pharmacotherapy 2003 Aug; 23(8): 979–87
Lilja JJ, Raaska K, Neuvonen PJ. Effects of grapefruit juice on the pharmacokinetics of acebutolol. Br J Clin Pharmacol 2005 Dec; 60(6): 659–63
Christensen H, Asberg A, Holmboe AB, et al. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers. Eur J Clin Pharmacol 2002 Nov; 58(8): 515–20
Doppenschmitt S, Spahn-Langguth H, Regardh CG, et al. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: an approach using passive membrane permeability and affinity to P-glycoprotein. J Pharm Sci 1999 Oct; 88(10): 1067–72
Edgar B, Regardh CG, Johnsson G, et al. Felodipine kinetics in healthy men. Clin Pharmacol Ther 1985 Aug; 38(2): 205–11
Pisarik P. Blood pressure-lowering effect of adding grapefruit juice to nifedipine and terazosin in a patient with severe renovascular hypertension. Arch Fam Med 1996 Jul–Aug;5(7): 413–6
Plendil (felodipine) tablets: summary of product characteristics. AstraZeneca UK Ltd. Updated 11/03/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Jul 22]
Stearns RA, Chakravarty PK, Chen R, et al. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes: role of cytochrome P4502C and 3A subfamily members. Drug Metab Dispos 1995 Feb; 23(2): 207–15
Kaukonen KM, Olkkola KT, Neuvonen PJ. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174. Eur J Clin Pharmacol 1998 Feb; 53(6): 445–9
Zaidenstein R, Soback S, Gips M, et al. Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers. Ther Drug Monit 2001 Aug; 23(4): 369–73
Varis T, Kaukonen KM, Kivisto KT, et al. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole. Clin Pharmacol Ther 1998 Oct; 64(4): 363–8
Varis T, Kivisto KT, Neuvonen PJ. Grapefruit juice can increase the plasma concentrations of oral methylprednisolone. Eur J Clin Pharmacol 2000 Sep; 56(6–7): 489–93
Varis T, Kivisto KT, Backman JT, et al. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Clin Pharmacol Ther 2000 Nov; 68(5): 487–94
Raaska K, Niemi M, Neuvonen M, et al. Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole. Clin Pharmacol Ther 2002 Oct; 72(4): 362–9
Hande K, Messenger M, Wagner J, et al. Inter- and intrapatient variability in etoposide kinetics with oral and intravenous drug administration. Clin Cancer Res 1999 Oct; 5(10): 2742–7
Reif S, Nicolson MC, Bisset D, et al. Effect of grapefruit juice intake on etoposide bioavailability. Eur J Clin Pharmacol 2002 Oct; 58(7): 491–4
Goldbart A, Press J, Sofer S, et al. Near fatal acute colchicine intoxication in a child: a case report. Eur J Pediatr 2000 Dec; 159(12): 895–7
Fujiwara K, Adachi H, Nishio T, et al. Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology 2001 May; 142(5): 2005–12
Kassem NA, Deane R, Segal MB, et al. Thyroxine (T4) transfer from CSF to choroid plexus and ventricular brain regions in rabbit: contributory role of P-glycoprotein and organic anion transporting polypeptides. Brain Res 2007 Nov 21; 1181: 44–50
Lilja JJ, Laitinen K, Neuvonen PJ. Effects of grapefruit juice on the absorption of levothyroxine. Br J Clin Pharmacol 2005 Sep; 60(3): 337–41
Schubert W, Cullberg G, Edgar B, et al. Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. Maturitas 1994 Dec; 20(2–3): 155–63
Weber A, Jager R, Borner A, et al. Can grapefruit juice influence ethinylestradiol bioavailability? Contraception 1996 Jan; 53(1): 41–7
Grande LA, Mendez RD, Krug RT, et al. Attention: grapefruit! Lancet 2009 Apr 4; 373(9670): 1222
Wang JS, DeVane CL. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. Drug Metab Dispos 2003 Jun; 31(6): 742–7
Benmebarek M, Devaud C, Gex-Fabry M, et al. Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone. Clin Pharmacol Ther 2004 Jul; 76(1): 55–63
Methadone solution for injection: summary of product characteristics. Wockhardt UK Ltd. Updated 02/09/2008 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Feb 2]
Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996 Jun; 8(2): 47–52
Ballard TL, Halaweish FT, Stevermer CL, et al. Naringin does not alter caffeine pharmacokinetics, energy expenditure, or cardiovascular haemodynamics in humans following caffeine consumption. Clin Exp Pharmacol Physiol 2006 Apr; 33(4): 310–4
Strauch K, Lutz U, Bittner N, et al. Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles. Food Chem Toxicol 2009 Aug; 47(8): 1928–35
Di Marco MP, Edwards DJ, Wainer IW, et al. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci 2002 Jul 26; 71(10): 1149–60
Hukkanen J, Jacob 3rd P, Benowitz NL. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance. Clin Pharmacol Ther 2006 Nov; 80(5): 522–30
Martin J, editor. British national formulary. 58th ed. London: RPS Publishing, 2009: 720–803, 932–46
Grapefruit diet: 12-day grapefruit diet plan [online]. Available from URL: http://www.grapefruit-diet.org [Accessed 2010 Feb 3]
Dallas C, Gerbi A, Tenca G, et al. Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes: mechanism of action by inhibition of cAMP-phosphodiesterase (PDE). Phytomedicine 2008 Oct; 15(10): 783–92
Greenblatt DJ. Analysis of drug interactions involving fruit beverages and organic anion-transporting polypeptides. J Clin Pharmacol 2009 Dec; 49(12): 1403–7
Inspra (eplerenone) tablets: summary of product characteristics. Pfizer Limited. Updated 19/11/2009 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Sep 28]
Xarelto (rivaroxaban) 10mg tablets: summary of product characteristics. Bayer plc. Updated 30/06/2010 [online]. Available from URL: http://www.medicines.org.uk [Accessed 2010 Sep 28]
Acknowledgments
The authors thank the National Institute of Health Research (NIHR-Department of Health) and the Northwest Development Agency (NWDA) for infrastructural and project support.
Transparency declaration: This review was in part funded by the Florida Department of Citrus (FDOC).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Seden, K., Dickinson, L., Khoo, S. et al. Grapefruit-Drug Interactions. Drugs 70, 2373–2407 (2010). https://doi.org/10.2165/11585250-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11585250-000000000-00000